Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 11 2023
Historique:
received: 18 07 2023
accepted: 23 10 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: epublish

Résumé

The BRCA2 tumour suppressor protein preserves genomic integrity via interactions with the DNA-strand exchange RAD51 protein in homology-directed repair. The RAD51-binding TR2 motif at the BRCA2 C-terminus is essential for protection and restart of stalled replication forks. Biochemical evidence shows that TR2 recognises filamentous RAD51, but existing models of TR2 binding to RAD51 lack a structural basis. Here we used cryo-electron microscopy and structure-guided mutagenesis to elucidate the mechanism of TR2 binding to nucleoprotein filaments of human RAD51. We find that TR2 binds across the protomer interface in the filament, acting as a brace for adjacent RAD51 molecules. TR2 targets an acidic-patch motif on human RAD51 that serves as a recruitment hub in fission yeast Rad51 for recombination mediators Rad52 and Rad55-Rad57. Our findings provide a structural rationale for RAD51 filament stabilisation by BRCA2 and reveal a common recruitment mechanism of recombination mediators to the RAD51 filament.

Identifiants

pubmed: 37919288
doi: 10.1038/s41467-023-42830-1
pii: 10.1038/s41467-023-42830-1
pmc: PMC10622577
doi:

Substances chimiques

DNA-Binding Proteins 0
Nucleoproteins 0
Rad51 Recombinase EC 2.7.7.-
BRCA2 Protein 0
RAD51 protein, human EC 2.7.7.-
BRCA2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7003

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Nat Rev Cancer. 2023 Feb;23(2):78-94
pubmed: 36471053
Nat Commun. 2016 Aug 08;7:12425
pubmed: 27498558
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Nat Struct Mol Biol. 2010 Oct;17(10):1260-2
pubmed: 20729859
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Cancer Cell. 2012 Jul 10;22(1):106-16
pubmed: 22789542
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6927-32
pubmed: 9192668
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Genet. 1996 May;13(1):22-3
pubmed: 8673099
Nat Methods. 2020 Sep;17(9):923-927
pubmed: 32807957
Nat Commun. 2023 Jan 26;14(1):432
pubmed: 36702902
Mol Cell. 2001 Feb;7(2):273-82
pubmed: 11239456
Nat Struct Mol Biol. 2023 Jan;30(1):115-124
pubmed: 36593312
Cancer Res. 1998 Aug 1;58(15):3441-7
pubmed: 9699678
Nat Struct Mol Biol. 2010 Oct;17(10):1263-5
pubmed: 20729858
Nature. 2002 Nov 21;420(6913):287-93
pubmed: 12442171
Nature. 2005 Mar 31;434(7033):598-604
pubmed: 15800615
EMBO J. 2007 Jun 20;26(12):2915-22
pubmed: 17541404
Nat Struct Mol Biol. 2007 Jun;14(6):468-74
pubmed: 17515904
Mol Cell. 2001 Feb;7(2):263-72
pubmed: 11239455
Science. 2023 Apr 28;380(6643):382-387
pubmed: 37104614
Nature. 1997 Apr 24;386(6627):804-10
pubmed: 9126738
Anal Biochem. 1996 May 1;236(2):371-3
pubmed: 8660525
Nat Commun. 2017 Sep 13;8(1):525
pubmed: 28904335
iScience. 2023 Apr 25;26(5):106689
pubmed: 37216117
Nat Struct Mol Biol. 2010 Nov;17(11):1305-11
pubmed: 20935632
Semin Cell Dev Biol. 2021 May;113:14-26
pubmed: 32653304
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
Nat Genet. 1997 Dec;17(4):423-30
pubmed: 9398843
Genes Chromosomes Cancer. 2003 Apr;36(4):317-31
pubmed: 12619154
J Biol Chem. 1997 Dec 19;272(51):31941-4
pubmed: 9405383
Elife. 2021 Jan 25;10:
pubmed: 33493431
Mol Cell. 2017 Sep 7;67(5):867-881.e7
pubmed: 28757209
Genes Dev. 2003 Dec 15;17(24):3017-22
pubmed: 14681210
Elife. 2018 Nov 09;7:
pubmed: 30412051
Nature. 2008 Feb 28;451(7182):1111-5
pubmed: 18264088
EMBO J. 2018 Apr 3;37(7):
pubmed: 29507080
Mol Cell. 1998 Feb;1(3):347-57
pubmed: 9660919
Cell. 2011 May 13;145(4):529-42
pubmed: 21565612
Nucleic Acids Res. 2015 Nov 16;43(20):9835-55
pubmed: 26354865
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5287-92
pubmed: 9560268
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
J Cell Biol. 2015 Mar 2;208(5):563-79
pubmed: 25733714
Nature. 2010 Oct 7;467(7316):678-83
pubmed: 20729832
Cancer Res. 2012 Jun 1;72(11):2814-21
pubmed: 22447567
Cold Spring Harb Symp Quant Biol. 2017;82:329-338
pubmed: 29686033
Mutat Res. 2014 Aug-Sep;766-767:66-72
pubmed: 25847274
Mol Cell. 2010 Feb 26;37(4):492-502
pubmed: 20188668
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188597
pubmed: 34332021
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
Nat Struct Mol Biol. 2007 Jun;14(6):475-83
pubmed: 17515903

Auteurs

Robert Appleby (R)

Department of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.

Luay Joudeh (L)

Department of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.

Katie Cobbett (K)

Department of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.

Luca Pellegrini (L)

Department of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK. lp212@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH